ATE242257T1 - Morphin-derivate - Google Patents

Morphin-derivate

Info

Publication number
ATE242257T1
ATE242257T1 AT98917345T AT98917345T ATE242257T1 AT E242257 T1 ATE242257 T1 AT E242257T1 AT 98917345 T AT98917345 T AT 98917345T AT 98917345 T AT98917345 T AT 98917345T AT E242257 T1 ATE242257 T1 AT E242257T1
Authority
AT
Austria
Prior art keywords
morphine
glucuronide
adducts
formula
acid
Prior art date
Application number
AT98917345T
Other languages
English (en)
Inventor
Feodor Scheinmann
Andrew Valentine Stachulski
Simon Joel
Smithfield
Original Assignee
Ufc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/833,203 external-priority patent/US5977326A/en
Priority claimed from GBGB9721137.9A external-priority patent/GB9721137D0/en
Application filed by Ufc Ltd filed Critical Ufc Ltd
Application granted granted Critical
Publication of ATE242257T1 publication Critical patent/ATE242257T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98917345T 1997-04-14 1998-04-14 Morphin-derivate ATE242257T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/833,203 US5977326A (en) 1991-08-06 1997-04-14 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
GBGB9721137.9A GB9721137D0 (en) 1997-10-07 1997-10-07 Morphine derivatives
PCT/GB1998/001071 WO1998046618A1 (en) 1997-04-14 1998-04-14 Morphine derivatives

Publications (1)

Publication Number Publication Date
ATE242257T1 true ATE242257T1 (de) 2003-06-15

Family

ID=26312371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98917345T ATE242257T1 (de) 1997-04-14 1998-04-14 Morphin-derivate

Country Status (9)

Country Link
EP (1) EP0975648B1 (de)
JP (1) JP2001518912A (de)
AT (1) ATE242257T1 (de)
AU (1) AU723859B2 (de)
DE (1) DE69815336T2 (de)
DK (1) DK0975648T3 (de)
ES (1) ES2201482T3 (de)
GB (1) GB2339196B (de)
WO (1) WO1998046618A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
FR2907121B1 (fr) 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
EP2116539A1 (de) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939436B1 (fr) 2008-12-10 2010-12-17 Sanofi Aventis Synthese de morphine-6-glucuronide ou de l'un de ses derives
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
EP2353598A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz
EP2353591A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon
EP2388005A1 (de) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie
EP2415471A1 (de) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie
EP2524694A1 (de) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes
TW201607538A (zh) 2013-12-17 2016-03-01 以斯提夫博士實驗室股份有限公司 血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325065D0 (en) * 1993-12-07 1994-02-02 Salford Ultrafine Chem & Res An enzymatic process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
WO1997021416A2 (es) * 1995-11-29 1997-06-19 Rolabo Sl Glicoconjugados de substancias opiaceas

Also Published As

Publication number Publication date
DE69815336T2 (de) 2004-05-06
DE69815336D1 (de) 2003-07-10
GB2339196B (en) 2001-11-07
EP0975648A1 (de) 2000-02-02
GB9924287D0 (en) 1999-12-15
AU7059098A (en) 1998-11-11
ES2201482T3 (es) 2004-03-16
AU723859B2 (en) 2000-09-07
GB2339196A8 (en) 2000-01-24
JP2001518912A (ja) 2001-10-16
DK0975648T3 (da) 2003-09-29
EP0975648B1 (de) 2003-06-04
GB2339196A (en) 2000-01-19
WO1998046618A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
DK0975648T3 (da) Morfinderivater
TR200200986T2 (tr) C-aril glukozid SGLT2 önleyicileri.
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
BG106104A (en) Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
CA2217006A1 (en) Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
EP0939627A4 (de) Pentafluorobenzensulfonamide und analoge
PT1071702E (pt) Derivados de acidos gordos de acidos biliares e derivados de acidos biliares
PL340551A1 (en) Derivatives of hydroxamic and carboxylic acids exhibiting mmp & tnf inhibitive action
DK399588A (da) Pentasaccharider
NO20002702L (no) Tienopyrimidiner
DE69915692D1 (de) Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
ATE253061T1 (de) Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide
FI971711A0 (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
ES2184318T3 (es) 6-alquilfenantridinas sustituidas.
ATE169217T1 (de) Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
DK0768084T3 (da) Kræftmetastaseinhibitor
PT659082E (pt) Utilizacao de inibidores de citocromo p450 para inibir o metabolismo de acridina substituida com azoto
EP0766963A4 (de) Wirkstoff gegen arteriosklerose
EP0660819A1 (de) Derivate von n,n,n',n'-tetrasubstituierte-1,2-ethanoldiamin-verbindungen.
SE0004462D0 (sv) Novel method and use
IL114185A0 (de)
PT828486E (pt) Utilizacao de derivados de pirrolidina no tratamento do alcoolismo
ID22762A (id) Komposisi untuk mengobati atau mencegah kanker prostat
MY103537A (en) Treatment of cardiac arrhythmias.
DE69826287D1 (de) Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975648

Country of ref document: EP

REN Ceased due to non-payment of the annual fee